{"filing":{"accession_number":"0001628280-26-045154","cik":"0001822462","ticker":"FHTX","company_name":"Foghorn Therapeutics Inc.","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"fhtx-20260624.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/fhtx-20260624.htm"},"events":[{"id":13466,"run_id":11965,"accession_number":"0001628280-26-045154","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Foghorn's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Douglas Cole, Simba Gill, and B. Lynne Parshall), ratification of Deloitte \u0026 Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory approval of voting frequency on executive compensation. The detailed vote counts for each proposal are the core content of Item 5.07.","company_name":"Foghorn Therapeutics Inc.","ticker":"FHTX","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10608,"accession_number":"0001628280-26-045154","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Foghorn's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Douglas Cole, Simba Gill, and B. Lynne Parshall), ratification of Deloitte \u0026 Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory approval of voting frequency on executive compensation. The detailed vote counts for each proposal are the core content of Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:02:36.829912+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10608,"accession_number":"0001628280-26-045154","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Foghorn's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Douglas Cole, Simba Gill, and B. Lynne Parshall), ratification of Deloitte \u0026 Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory approval of voting frequency on executive compensation. The detailed vote counts for each proposal are the core content of Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:02:36.829912+00:00","company_name":"Foghorn Therapeutics Inc.","ticker":"FHTX","filing_date":"2026-06-24"}]}